HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Maggi Selected Research

Neoplasms (Cancer)

9/2022The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells.
1/2022Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
1/2021Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview.
3/2020Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study.
12/2018Testosterone deficiency in non-cancer opioid-treated patients.
3/2011Androgen regulation of prostate cancer: where are we now?
6/2004Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue.
2/2004Somatostatin receptors in non-endocrine tumours.
12/2001Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens.
6/2001Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan technology.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Maggi Research Topics

Disease

24Hypogonadism (Hypergonadotropic Hypogonadism)
05/2022 - 08/2002
14Erectile Dysfunction
01/2017 - 08/2000
13Neoplasms (Cancer)
09/2022 - 10/2000
9Inflammation (Inflammations)
07/2022 - 06/2010
7Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2022 - 12/2002
6Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 12/2008
6Obesity
12/2020 - 08/2004
6Prostatic Neoplasms (Prostate Cancer)
03/2011 - 09/2001
5Insulin Resistance
04/2021 - 10/2009
5Infertility (Sterility)
11/2014 - 09/2010
4Lower Urinary Tract Symptoms
07/2022 - 07/2006
4Breast Neoplasms (Breast Cancer)
06/2004 - 06/2001
3Prostatitis
07/2022 - 06/2010
3Atrophy
06/2022 - 07/2003
3Infections
04/2022 - 12/2011
3Fibrosis (Cirrhosis)
10/2021 - 01/2008
3Diabetes Mellitus
01/2016 - 03/2006
3Hypertension (High Blood Pressure)
12/2015 - 12/2008
3Abdominal Obesity
06/2014 - 12/2008
3Gynecomastia
06/2014 - 09/2012
3Hypoxia (Hypoxemia)
01/2008 - 12/2002
2Hyponatremia
09/2022 - 08/2020
2Euthyroid Sick Syndromes (Euthyroid Sick Syndrome)
04/2022 - 01/2022
2COVID-19
03/2022 - 01/2022
2Disease Progression
01/2021 - 04/2014
2Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2019 - 03/2019
2Pain (Aches)
12/2018 - 01/2014
2Ejaculatory Dysfunction
11/2013 - 02/2011
2Hyperthyroidism
10/2012 - 11/2004
2Type 2 Diabetes Mellitus (MODY)
12/2011 - 12/2008
2Hyperprolactinemia
06/2011 - 12/2005
2Hyperplasia
04/2004 - 07/2003
2Colonic Neoplasms (Colon Cancer)
02/2004 - 06/2001
2Adenocarcinoma
12/2001 - 11/2000
2Neuroblastoma
06/2001 - 01/2001
1Autistic Disorder (Autism)
11/2022
1Bone Resorption
05/2022
1Pneumonia (Pneumonitis)
03/2022
1Paraganglioma (Paragangliomas)
01/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022
1Pheochromocytoma
01/2022
1Thyroid Diseases (Thyroid Disease)
12/2021
1Alcoholic Fatty Liver
10/2021
1Non-alcoholic Fatty Liver Disease
04/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Klinefelter Syndrome (Klinefelter's Syndrome)
12/2020

Drug/Important Bio-Agent (IBA)

37Testosterone (Sustanon)FDA Link
07/2022 - 06/2004
16AndrogensIBA
12/2018 - 12/2001
9Messenger RNA (mRNA)IBA
10/2021 - 10/2000
6Biomarkers (Surrogate Marker)IBA
04/2022 - 12/2009
5Estrogens (Estrogen)FDA Link
05/2022 - 09/2001
5Interleukin-8 (Interleukin 8)IBA
01/2014 - 06/2010
5Somatostatin Receptors (Somatostatin Receptor)IBA
06/2004 - 01/2001
4Tadalafil (Cialis)FDA Link
08/2019 - 09/2008
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
12/2015 - 08/2002
4Proteins (Proteins, Gene)FDA Link
07/2003 - 01/2001
3LipidsIBA
04/2021 - 03/2011
3GonadotropinsIBA
11/2014 - 12/2009
3Glucose (Dextrose)FDA LinkGeneric
06/2014 - 11/2004
3Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
06/2014 - 09/2008
3Phosphodiesterase 5 InhibitorsIBA
03/2013 - 12/2005
3BXL628IBA
06/2010 - 04/2004
3Endothelin-1 (Endothelin 1)IBA
01/2008 - 12/2001
3Calcitriol (Calcijex)FDA LinkGeneric
07/2006 - 07/2003
2Hormones (Hormone)IBA
11/2022 - 12/2001
2Triglycerides (Triacylglycerol)IBA
04/2021 - 12/2009
2LigandsIBA
03/2020 - 01/2014
2AntigensIBA
03/2020 - 06/2010
2Bleomycin (Blenoxane)FDA LinkGeneric
08/2019 - 03/2019
2Therapeutic UsesIBA
08/2019 - 03/2019
2obeticholic acidIBA
08/2019 - 03/2019
2Finasteride (Propecia)FDA LinkGeneric
01/2017 - 04/2004
2tyramine-deoxysorbitolIBA
09/2016 - 11/2007
2Pharmaceutical PreparationsIBA
12/2015 - 08/2002
2Vardenafil Dihydrochloride (Levitra)FDA Link
09/2015 - 09/2008
2HDL CholesterolIBA
06/2014 - 12/2008
2omega-Chloroacetophenone (Mace)IBA
06/2011 - 07/2010
2ProlactinIBA
06/2011 - 02/2011
2Sildenafil Citrate (Viagra)FDA Link
09/2008 - 01/2008
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2004 - 01/2001
2Progesterone Receptors (Progesterone Receptor)IBA
06/2004 - 06/2001
2Estrogen ReceptorsIBA
06/2004 - 06/2001
2ClusterinIBA
04/2004 - 07/2003
2RNA (Ribonucleic Acid)IBA
06/2001 - 10/2000
2somatostatin receptor 2IBA
01/2001 - 10/2000
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
09/2022
1ElectrolytesIBA
09/2022
1TolvaptanFDA Link
09/2022
1SodiumIBA
09/2022
1Anabolic AgentsIBA
05/2022
1Triiodothyronine (Liothyronine)FDA LinkGeneric
04/2022
1CatecholaminesIBA
01/2022
1C.I. direct red 80IBA
10/2021
1ProdrugsIBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
08/2020
1Immune Checkpoint InhibitorsIBA
03/2020

Therapy/Procedure

20Therapeutics
07/2022 - 08/2000
4Drug Therapy (Chemotherapy)
05/2021 - 04/2003
1Injections
10/2021
1Radiotherapy
01/2021